UBS Group’s ARYA Sciences Acquisiton Corp. Unit ARYAU Stock Holding History

UBS Group’s Portfolio ARYAU Stock Details ARYAU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-103	Closed	-$2K	–	8825
2020 Q2	$2K	Sell	103 -113	-52%	-$1.65K	﹤0.01%	7713
2020 Q1	$2K	Buy	216 +100	+86%	+$1.15K	﹤0.01%	7698
2019 Q4	$1K	Hold	116	–	–	﹤0.01%	8046
2019 Q3	$1K	Sell	116 -1,200	-91%	-$13K	﹤0.01%	7912
2019 Q2	$14K	Sell	1,316 -1,724	-57%	-$18.2K	﹤0.01%	6876
2019 Q1	$31K	Buy	3,040 +2,200	+262%	+$22.8K	﹤0.01%	5929
2018 Q4	$9K	Buy	+840	New	+$8.65K	﹤0.01%	7312

UBS Group's ARYAU Position: Q3 2020 in Review

UBS Group sold out of ARYA Sciences Acquisiton Corp. Unit (ARYAU) in Q3 2020, closing a stake of 103 shares — an estimated $2K sold.

UBS Group first reported a position in ARYAU in Q4 2018 and held it in 7 quarters. The position peaked at $31K in Q1 2019. 0 funds tracked by Wall St. Rank hold ARYAU as of Q3 2020.

UBS Group reported no remaining ARYA Sciences Acquisiton Corp. Unit position as of Q3 2020 after selling out during the quarter.
UBS Group sold 103 ARYA Sciences Acquisiton Corp. Unit shares in Q3 2020, an estimated $2K.
UBS Group first reported a position in ARYA Sciences Acquisiton Corp. Unit in Q4 2018 and held it in 7 quarters.
UBS Group's ARYA Sciences Acquisiton Corp. Unit position peaked at $31K in Q1 2019.
0 funds tracked by Wall St. Rank held ARYA Sciences Acquisiton Corp. Unit as of Q3 2020.

Based on UBS Group's 13F filing for Q3 2020, filed 12 Nov 2020.